New pill aims to tame relapsed lymphomas in early trial
Disease control
Recruiting now
This early-phase study tests an experimental oral drug called AUR108 in adults with relapsed advanced lymphomas (cancers of the immune system). The main goals are to check the drug's safety, find the right dose, and see how the body processes it. About 40 participants will take t…
Phase: PHASE1 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 01, 2026 15:59 UTC